Statins stabilize the renal function of IgA nephropathy

Renal Failure

Volumn 36, Issue 3, 2014, Pages 356-360

  Moriyama, Takahito ^a   Oshima, Yasuko ^a   Tanaka, Kayu ^a   Iwasaki, Chihiro ^a   Ochi, Ayami ^a   Itabashi, Mitsuyo ^a   Takei, Takashi ^a   Uchida, Keiko ^a   Nitta, Kosaku ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

3 hydroxy 3 methylglutaryl coenzyme A reductase inhibitors; IgA nephropathy; Proteinuria; Renal function; Statin

Indexed keywords

ALBUMIN; ATORVASTATIN; CREATININE; FLUINDOSTATIN; HIGH DENSITY LIPOPROTEIN; IMMUNOSUPPRESSIVE AGENT; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PITAVASTATIN; PRAVASTATIN; PROTEIN; ROSUVASTATIN; SERUM ALBUMIN; SIMVASTATIN; STEROID; TRIACYLGLYCEROL; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COHORT ANALYSIS; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; DRUG EFFICACY; ERYTHROCYTE; ERYTHROCYTE URINE LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY FUNCTION; LIPID METABOLISM; MALE; MEAN ARTERIAL PRESSURE; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; PROTEINURIA; RETROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; UREA NITROGEN BLOOD LEVEL; URIC ACID BLOOD LEVEL; BLOOD; GLOMERULONEPHRITIS, IGA; HEMATURIA; HYPERLIPIDEMIAS; KIDNEY; METABOLISM; PATHOPHYSIOLOGY;

ADULT; CHOLESTEROL; CREATININE; FEMALE; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS, IGA; HEMATURIA; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; KIDNEY; MALE; MIDDLE AGED; PROTEINURIA; RETROSPECTIVE STUDIES; TRIGLYCERIDES;

EID: 84896452578     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2013.866512     Document Type: Article

References (17)

1. Nitta K. Clinical assessment and management of dyslipidemia in patients with chronic kidney disease. Clin Exp Nephrol. 2012;16: 522-529.
2. Baigent C, Landray MJ, Reith C, et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randmised placebo-controlled trial. Lancet. 2011;377:2181-2192.
3. Jenkins M, Goldsmith D. Statins and kidney disease: is the study of heart and renal protection at cutting edge of evidence? Curr Opin Cardiol. 2012;27:429-440.
4. Strippoli GF, Navaneethan SD, Johnson DW, et al. Effects of statins in patients with chronic kidney disease: meta-analysis and metaregression of randomized control trials. BMJ. 2008;336:645-651.
5. Sandhu S, Wiebe N, Fried LF, Tonelli M. Statins for improving renal outcomes. J Am Soc Nephrol. 2006;17:2006-2016.
6. Wu Y, Wang Y, An C, et al. Effects of rosuvastatin and atorvastatin on renal function - meta-analysis. Circ J. 2012;76:1259-1266.
7. Savarese G, Musella F, Volpe M, Paneni F, Perrone-Filardi P. Effects of atorvastatin and rosuvastatin on renal function: a metaanalysis. Int J Cardiol. 2013;167:2482-2489.
8. Kalaitzidis RG, Elisaf M. The role of statins in chronic kidney disease. Am J Nephrol. 2011;34:195-202.
9. Fujita E, Shimizu A, Masuda Y, et al. Statin attenuates experimental anti-glomerular basement membrane gromerulonephritis together with the augmention of alternatively activated macrophages. Am J Pathol. 2010;177:1143-1154.
10. Eller P, Eller K, Wolf AM, et al. Atorvastatin attenuates murin antiglomerular basement membrane glomerulonephritis. Kidney Int. 2010;77:428-435.
11. Krämer S, Kron S, Wang-Rosenke Y, et al. Rosuvastatin is additive to high-dose candesartan in slowing progression of experimental mesangioproliferative glomerulosclerosis. Am J Physiol Renal Physiol. 2008;294:F801-F811.
12. Wei J, Ma C, Wang X. Simvastatin inhibits tissue factor and activator inhibitor-1 expression of glomerular mesangial cells in hypercholesterolemic rabbits. Biomed Res. 2006;27: 149-155.
13. Sarafidis PA. Statin pleiotropy against renal injury. J Cardiometab Syndr. 2009;4:E4-E9.
14. Buemi M, Allegra A, Corica F, et al. Effect of fluvastatin on proteinuria in patients with immunoglobulin A nephropathy. Clin Pharmacol Ther. 2000;67:427-431.
15. Kano K, Nishikura K, Yamada Y, Arisaka O. Effect of fluvastatin and dipyridamole on proteinuria and renal function in childhood IgA nephropathy with mild histological findings and moderate proteinuria. Clin Nephrol. 2003;60:85-89.
16. Lundberg S, Lundahl J, Gunnarsson I, Jacobson SH. Atorvastatininduced modulation of monocyte respiratory burst in vivo patients with IgA nephropathy: a chronic inflammatory kidney disease. Clin Nephrol. 2010;73:221-228.
17. Nakamura T, Ushiyama C, Hirokawa K, et al. Effect of cerivastatin on proteinuria and urinary podocytes in patients with chronic glomerulonephritis. Nephrol Dial Transplant. 2002;17:798-802.